The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis
Here's a roundup of top developments in the biotech space over the last 24 hours.
Seagen Wins $42M Patent Claim Against Daiichi In Cancer Drug Case
A jury in Marshall, Texas, awarded Seagen Inc (NASDAQ: SGEN)
AstraZeneca’s Enhertu Meets Primary Endpoint In HER2-Low Breast Cancer Setting
AstraZeneca plc (NASDAQ: AZN) said that
Esperion Chops 40% Workforce As Launch Of Cholesterol Medication Falters
Esperion Therapeutics Inc's (NASDAQ: ESPR) cholesterol drug marketing strategy has soured badly, as it has been struggling to sell its heart disease pill for more than a year.
AstraZeneca’s Enhertu Posts Substantial Clinical Benefit Over Roche’s Kadcyla In Breast Cancer Trials
AstraZeneca Plc (NASDAQ: AZN) and Daiichi Sankyo's (OTC: DSNKY) Enhertu have shown some striking data in late-stage breast cancer trials and early solid tumor tests.
AstraZeneca, Daiichi Sankyo’s Enhertu Shows Improved PFS Over Roche’s Kadcyla In Breast Cancer
AstraZeneca plc (NASDAQ:AZN) and Daiichi Sankyo Co Ltd (OTC:DSKYF) have announced high-level results from the head-to-head DESTINY-Breast03 Phase 3 trial of Enhertu. The…
Daiichi Sankyo – AstraZeneca Start Dosing In Head-To-Head Stomach Cancer Trial With Enhertu
Daiichi Sankyo Co Ltd (OTC:DSKYF) and AstraZeneca plc (NASDAQ: AZN) have dosed the first patient in DESTINY-Gastric04, Phase 3 trial of Enhertu (trastuzumab deruxtecan)…
Daiichi Sankyo To Stop Testing Inhaled Nafamostat In COVID-19 Patients In Japan
Daiichi Sankyo Co Ltd (OTC:DSNKY) said it was halting the development of an existing drug for the treatment of COVID-19 without…
Nipro To Provide Fill, Finish Services For AstraZeneca COVID-19 Shots In Japan: Reuters
Japan’s Nipro Corporation has signed an agreement to supply AstraZeneca Plc’s (NASDAQ: AZN) COVID-19 vaccine in Japan, reports Reuters. Nipro said that the…